Benjamin Greenberg, MD

Articles by Benjamin Greenberg, MD

Overview and Prevalence of Multiple Sclerosis (MS)

ByAhmed Obeidat, MD, PhD,Benjamin Greenberg, MD,Hesham Abboud, MD, PhD

August 22nd 2022

Ahmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, discuss the prevelance of multiple sclerosis and comment on the mechanisms of action and available drug classes utilized in disease management.

Benjamin Greenberg, MD

Articles by Benjamin Greenberg, MD

Overview and Prevalence of Multiple Sclerosis (MS)

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Approves Levacetylleucine for Ataxia-Telangiectasia

FDA Clears Phase 1b/2 Trial of CAR T-Cell Therapy C-CAR168 for Refractory Progressive Multiple Sclerosis

FDA Approves UX111, First Gene Therapy for Pediatric Sanfilippo Syndrome Type A

Episode 175: Advancing the Ways of Treating Cluster Headache

10 Years of Progress: A Timeline of FDA Approvals for Duchenne Muscular Dystrophy